Abiopharma

🔍 Global GP LLC (Executive)

Company: GLOBAL PARTNERS LP (GLP)

Report Date: 2026-04-14

Detailed Transactions and Holdings:

• Sold 3,393 shares of Common units representing limited partner interests at $45.86 per share (Direct)
  Date: 2026-04-14 | Code: J | equity_swap_involved: 0 | shares_owned_after: 20,760.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 1,640 shares of Common units representing limited partner interests at $45.86 per share (Direct)
  Date: 2026-04-14 | Code: J | equity_swap_involved: 0 | shares_owned_after: 22,400.00 | transaction_form_type: 4 | Footnotes: F4, F2, F3

Footnotes:

• F1: The Reporting Person is delivering common units representing limited partner interests in the Issuer ("Common Units") under the Global Partners LP Long-Term Incentive Plan ("LTIP") to satisfy its obligations pursuant to a grant agreement dated April 14, 2025.
• F2: The Issuer's closing price on April 13, 2026 (the last business day immediately prior to vesting).
• F3: The Reporting Person disclaims any pecuniary interest in the Common Units and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the Common Units for purposes of Section 16.
• F4: The Reporting Person withheld Common Units from the grant award recipient who elected a cashless exercise to satisfy their respective tax withholding obligations. As a result, the Reporting Person held 22,400 Common Units after giving effect to the delivery of 3,393 Common Units to satisfy its obligations under the grant agreements less 1,640 Common Units that were withheld by the Reporting Person for tax purposes prior to such delivery.